Targeting Mutant Dicer Tumorigenesis in Pleuropulmonary Blastoma via Inhibition of RNA Polymerase I.

[1]  Bingshu E. Chen,et al.  Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies , 2022, Nature Communications.

[2]  Y. Messinger,et al.  Expression of p53 is significantly associated with recurrence-free survival and overall survival in pleuropulmonary blastoma (PPB): a report from the International Pleuropulmonary Blastoma/DICER1 Registry , 2021, Modern Pathology.

[3]  Shondra M. Pruett-Miller,et al.  The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma , 2021, Nature Communications.

[4]  S. Elledge,et al.  The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning , 2020, Proceedings of the National Academy of Sciences.

[5]  H. Shimada,et al.  Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression. , 2019, Journal of pediatric surgery.

[6]  R. Pearson,et al.  First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematological Cancers: Results of a Phase I Dose Escalation Study. , 2019, Cancer discovery.

[7]  Jung Kim,et al.  The prevalence of germline DICER1 pathogenic variation in cancer populations , 2019, Molecular genetics & genomic medicine.

[8]  B. Carter,et al.  Primary Lung Tumors in Children: Radiologic-Pathologic Correlation From the Radiologic Pathology Archives. , 2018, Radiographics : a review publication of the Radiological Society of North America, Inc.

[9]  R. Martienssen,et al.  New roles for Dicer in the nucleolus and its relevance to cancer , 2017, Cell cycle.

[10]  R. Martienssen,et al.  Transcriptional reprogramming in cellular quiescence , 2017, RNA biology.

[11]  B. Roche,et al.  RNA interference is essential for cellular quiescence , 2016, Science.

[12]  Trey Ideker,et al.  A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. , 2016, Molecular cell.

[13]  K. Khanna,et al.  Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling , 2016, Oncotarget.

[14]  P. Sethupathy,et al.  Essential Function of Dicer in Resolving DNA Damage in the Rapidly Dividing Cells of the Developing and Malignant Cerebellum. , 2016, Cell reports.

[15]  Gretchen M. Williams,et al.  Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model. , 2015, F1000Research.

[16]  P. Brown,et al.  rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis , 2015, Oncotarget.

[17]  K. Wikenheiser-Brokamp,et al.  Cell‐ and developmental stage‐specific Dicer1 ablation in the lung epithelium models cystic pleuropulmonary blastoma , 2015, The Journal of pathology.

[18]  A. Toker,et al.  Radiologic diagnosis of a type-III pleuropulmonary blastoma. , 2014, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.

[19]  J. Doudna,et al.  Evolutionarily Conserved Roles of the Dicer Helicase Domain in Regulating RNA Interference Processing* , 2014, The Journal of Biological Chemistry.

[20]  A. Jakymiw,et al.  Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells , 2014, Molecular Cancer.

[21]  Trevor J Pugh,et al.  Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences , 2014, Oncogene.

[22]  R. Hannan,et al.  Targeting RNA polymerase I to treat MYC-driven cancer , 2014, Oncogene.

[23]  A. Ferrari,et al.  Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. , 2014, European journal of cancer.

[24]  Tom H. Cheung,et al.  Molecular regulation of stem cell quiescence , 2013, Nature Reviews Molecular Cell Biology.

[25]  P. Choyke,et al.  Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies. , 2013, Radiology.

[26]  M. Lindström,et al.  p53 -Dependent and -Independent Nucleolar Stress Responses , 2012, Cells.

[27]  N. André,et al.  DICER1 Mutations in embryonal rhabdomyosarcomas from children with and without familial PPB‐tumor predisposition syndrome , 2012, Pediatric blood & cancer.

[28]  Carleen Cullinane,et al.  Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. , 2012, Cancer cell.

[29]  Arjun Bhutkar,et al.  In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. , 2012, RNA.

[30]  Piero Carninci,et al.  Site-specific DICER and DROSHA RNA products control the DNA damage response , 2012, Nature.

[31]  Yun-Gui Yang,et al.  A Role for Small RNAs in DNA Double-Strand Break Repair , 2012, Cell.

[32]  Steven J. M. Jones,et al.  Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. , 2012, The New England journal of medicine.

[33]  Stephane E. Castel,et al.  RNAi promotes heterochromatic silencing through replication-coupled release of RNA polII , 2011, Nature.

[34]  C. Colovos,et al.  Pre‐Clinical Mouse Models of Primary and Metastatic Pleural Cancers of the Lung and Breast and the Use of Bioluminescent Imaging to Monitor Pleural Tumor Burden , 2011, Current protocols in pharmacology.

[35]  Gretchen M. Williams,et al.  Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. , 2011, Gynecologic oncology.

[36]  R. Hannan,et al.  Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. , 2011, Cancer research.

[37]  W. Filipowicz,et al.  Dicer Is Associated with Ribosomal DNA Chromatin in Mammalian Cells , 2010, PloS one.

[38]  T. Seyama,et al.  An orthotopic implantation mouse model of human malignant pleural mesothelioma for in vivo photon counting analysis and evaluation of the effect of S‐1 therapy , 2010, International journal of cancer.

[39]  Keara M. Lane,et al.  Dicer1 functions as a haploinsufficient tumor suppressor. , 2009, Genes & development.

[40]  Gretchen M. Williams,et al.  DICER1 Mutations in Familial Pleuropulmonary Blastoma , 2009, Science.

[41]  Sean R. Collins,et al.  Conservation and Rewiring of Functional Modules Revealed by an Epistasis Map in Fission Yeast , 2008, Science.

[42]  Gretchen M. Williams,et al.  Familial association of pleuropulmonary blastoma with cystic nephroma and other renal tumors: a report from the International Pleuropulmonary Blastoma Registry. , 2006, The Journal of pediatrics.